Ischemia
-reduction in blood flow to levels insufficient to meet tissue oxygen demands
Infarction
-ischemic necrosis in an organ
Primary hypercholesterolemia
-familial hypercholesterolemia; LDL receptor deficiency/ dysfunction with marked elevated levels
Secondary hypercholesterolemia
-obesity, high calorie intake, diabetes mellitus
-LDL levels exceed receptor efficiency
statins, resins, cholesterol inhibitors, niacin, fibrates
Major medications for hyperlipidemia?
fatty streaks, fibrous atheromatous plaques, complicated lesions
What are the 3 pathogenic results of artherosclerosis?
Fatty streaks
thin, fatty, intimal plaques composed of macrophages and smooth muscle cells with lipids to form foam cells; attracts monocytes
Fibrous atheromatous plaques
-large, fibrous plaques with inflammation that may occlude vessel causing thrombus formation
Complicated lesions
-contain hemorrhage, ulceration, scar tissue
damage; inflammatory response
Atherosclerosis will eventually _________ endothelium; resulting in ________
ingest; large foam cells
Monocytes _____________ oxidized LDL; turn into _________
tunica media; tunica intima; cytokines
Smooth muscle proliferation and migration from _________ to the __________ in response to ________ secreted by damaged endothelial cells.
rate-limiting of mevalonate
HMG CoA Reductase Inhibitors (statins) inhibit what step?
raynaud's disease
primary type; no known cause
raynaud's phenomenon
secondary type; associated with other disease states or known causes of vasospasms
etiology of raynauds
-sympathetic vasoconstriction causing vasospams resulting in ischemia
pathogenesis of raynaud disease
Exposure to cold, stress, strong emotion
pathogenesis of raynaud phenomenon
trauma, occupational traumas, collagen diseases, neruological disorders, hot-cold exposures
etiology and pathogensis of venous thrombosis
stasis of blood, increased coagulation, vessel wall injury, spinal cord injury, impaired cardiac function
compression, heparin, warfarin
treatment for venous thrombosis
beta-adrenergic antagonists, surgical grafts
treatment for aneurysms